Blogs

Guideline on good pharmacovigilance practices (GVP): Module XVI Addendum II – Methods for evaluating effectiveness of risk minimisation measures

Guideline on good pharmacovigilance practices (GVP) Module XVI – Risk minimisation measures

Guideline on good pharmacovigilance practices: Module XV – Safety communication

Guideline on good pharmacovigilance practices: Module X – Additional monitoring

Guideline on good pharmacovigilance practices (GVP): Module IX – Signal management

Guideline on good pharmacovigilance practices (GVP): Module VIII Addendum I – Requirements and recommendations for the submission of information on non-interventional post-authorisation safety studies

Guideline on good pharmacovigilance practices (GVP) – Module VIII – Post-authorisation safety studies

Guideline on good pharmacovigilance practices (GVP): Module VII – Periodic safety update report

Guideline on good pharmacovigilance practices (GVP) – Module VI Addendum I – Duplicate management of suspected adverse reaction reports

Guideline on good pharmacovigilance practices (GVP) – Module VI – Collection, management and submission of reports of suspected adverse reactions to medicinal products
1 2 3 … 71

Hello
Chat now via Whatsapp